LIFE Stock Recent News

Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States

Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States Not for distribution to United States newswire services or for release publication, distribution, or dissemination directly, or indirectly, in whole or in part, in or into the United States

MCKINNEY, Texas , Feb. 27, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) announced that its Board of Directors has raised the quarterly dividend to $.2700 per share on all of the outstanding common stock of the Company held of record as of close of business of the Company's transfer agent on April 3, 2025. The dividend will be paid on May 1, 2025.

Toronto, Ontario--(Newsfile Corp. - February 27, 2025) -  DiagnaMed Holdings Corp. (CSE: DMED) (OTCQB: DGNMF) ("DiagnaMed" or the "Company"), a leading provider of cutting-edge technology solutions for the hydrogen and life sciences industries, is pleased to announce that it is arranging a private placement of a minimum of $350,000 and a maximum of $510,000 of units (each, a "Unit"), at a price of $0.03 per Unit; (the "Offering"). The Offering is being led by EMD Financial Inc. Each Unit will be comprised of one common share ("Common Share") in the capital of the Company and one (1) Common Share purchase warrant ("Warrant") of the Company.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR  FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, Feb. 26, 2025 (GLOBE NEWSWIRE) -- Hydreight Technologies Inc. (TSXV: NURS) ("Hydreight" or the "Company"), a North American, fully integrated, mobile clinical network of nurses, doctors, and pharmacy distribution, is pleased to announce that, further to the news releases of the Company dated February 10, 2025, and February 18, 2025, it has closed its previously announced commercially reasonable “best efforts” private placement with Beacon Securities Limited (the "Agent") acting as the sole agent. The Company issued 3,492,300 units of the Company (each, a "Unit") at a price of $1.55 per Unit for aggregate gross proceeds of $5,413,065 (the “Offering”).

- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES -

- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES -

- NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES - - NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES -

THOUSAND OAKS, Calif. , Feb. 7, 2025 /PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the 35th Annual Oppenheimer Healthcare Life Sciences Conference at 11:20 a.m.

MCKINNEY, Texas , Feb. 5, 2025 /PRNewswire/ -- Globe Life Inc. (NYSE: GL) reported today that for the quarter ended December 31, 2024, net income was $3.01 per diluted common share, compared with $2.88 per diluted common share for the year-ago quarter. Net operating income for the quarter was $3.14 per diluted common share, compared with $2.80 per diluted common share for the year-ago quarter.